Comment: is response-adaptive randomization a ``good thing or not in clinical trials? Why we cannot take sides
From MaRDI portal
Publication:6111467
DOI10.1214/23-STS865EOpenAlexW4379415064MaRDI QIDQ6111467
Publication date: 7 July 2023
Published in: Statistical Science (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1214/23-sts865e
modelling and simulationBayesian response-adaptive randomizationdoubly adaptivesimply adaptiveThompson's sampling
Cites Work
- Unnamed Item
- Bayesian doubly adaptive randomization in clinical trials
- Ethics and statistics in randomized clinical trials. With comments and a rejoinder by the author
- The doubly adaptive weighted differences design
- Bayesian adaptive randomization with compound utility functions
- Simulation of clinical trials: a review with emphasis on the design issues
- Asymptotically Optimal Response‐Adaptive Designs for Allocating the Best Treatment: An Overview
- Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses
This page was built for publication: Comment: is response-adaptive randomization a ``good thing or not in clinical trials? Why we cannot take sides